SAM
BPMC

Shell Asset Management’s Blueprint Medicines BPMC Stock Holding History

Shell Asset Management’s Portfolio BPMC Stock Details BPMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-4,448
Closed -$195K – 1263
2022
Q4 		$195K Sell
4,448
-903
-17% -$43.3K 0.01% 964
2022
Q3 		$353K Sell
5,351
-1,404
-21% -$90.2K 0.01% 748
2022
Q2 		$341K Buy
6,755
+10
+0.1% +$586 0.01% 919
2022
Q1 		$431K Sell
6,745
-999
-13% -$71.7K 0.01% 877
2021
Q4 		$829K Buy
7,744
+31
+0.4% +$3.24K 0.02% 656
2021
Q3 		$793K Sell
7,713
-330
-4% -$30.7K 0.02% 617
2021
Q2 		$707K Buy
8,043
+440
+6% +$40.3K 0.01% 745
2021
Q1 		$739K Buy
7,603
+2,954
+64% +$295K 0.01% 663
2020
Q4 		$521K Buy
4,649
+697
+18% +$73.5K 0.01% 784
2020
Q3 		$366K Hold
3,952
– – 0.01% 817
2020
Q2 		$308K Sell
3,952
-87
-2% -$5.88K 0.01% 887
2020
Q1 		$236K Sell
4,039
-62
-2% -$3.99K 0.01% 956
2019
Q4 		$329K Sell
4,101
-130
-3% -$9.73K 0.01% 1030
2019
Q3 		$311K Sell
4,231
-37
-0.9% -$3.2K 0.01% 1056
2019
Q2 		$403K Sell
4,268
-98
-2% -$8.09K 0.01% 996
2019
Q1 		$349K Hold
4,366
– – 0.01% 1022
2018
Q4 		$235K Sell
4,366
-400
-8% -$24.3K 0.01% 1019
2018
Q3 		$372K Hold
4,766
– – 0.01% 1033
2018
Q2 		$303K Sell
4,766
-269
-5% -$21.4K 0.01% 1021
2018
Q1 		$462K Hold
5,035
– – 0.01% 931
2017
Q4 		$380K Buy
+5,035
New +$354K 0.01% 972

Other funds holding BPMC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Shell Asset Management's BPMC Position: Q1 2023 in Review

Shell Asset Management sold out of Blueprint Medicines (BPMC) in Q1 2023, closing a stake of 4,448 shares — an estimated $195K sold.

Shell Asset Management first reported a position in BPMC in Q4 2017 and held it in 21 quarters. The position peaked at $829K in Q4 2021. 214 funds tracked by Wall St. Rank hold BPMC as of Q1 2023.

  • Shell Asset Management reported no remaining Blueprint Medicines position as of Q1 2023 after selling out during the quarter.
  • Shell Asset Management sold 4,448 Blueprint Medicines shares in Q1 2023, an estimated $195K.
  • Shell Asset Management first reported a position in Blueprint Medicines in Q4 2017 and held it in 21 quarters.
  • Shell Asset Management's Blueprint Medicines position peaked at $829K in Q4 2021.
  • 214 funds tracked by Wall St. Rank held Blueprint Medicines as of Q1 2023.

Based on Shell Asset Management's 13F filing for Q1 2023, filed 15 May 2023.